Corrigendum: Anti-cancer potential of polysaccharide extracted from Polygonatum sibiricum on HepG2 cells via cell cycle arrest and apoptosis

In the published article, there was an error in Figure 5B. The effect of PSP-1 (200 μg/mL) on MMP in Figure 5B was wrongly used. The corrected Figure 5B and its caption appear below.

Figure 5.

The morphological changes of HepG2 cells treated with 0, 100, 200, and 400 μg/mL of PSP-1 for 72 h (A), the morphological characterization of HepG2 cells was observed and photographed under a Confocal laser scanning microscope (A1), nuclear morphological changes induced by PSP-1 in HepG2 cells after DAPI staining. (A2) Effect of PSP-1 on MMP (B) Cell cycle progression was assessed using propidium iodide staining detected by fluorescence activated cell sorting. (C) The apoptotic rates of the indicated cells induced by PSP-1 at different concentrations for 72 h were detected by ANNexin V/PI double-staining asssy (D).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.